Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28253383 | 0.78 | RAB9A (0.41) | KDM4EMEN1MAPTKMT2AIDO1 | |
| SCHEMBL3789321 | 0.78 | MAOA (0.45) | KDM4EMEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL28209751 | 0.70 | CYP2E1 (0.32) | MEN1KMT2ASMN1; SMN2TP53 | |
| SCHEMBL198702 | 0.70 | TAAR1 (0.68) | KDM4EMEN1MAPTKMT2ATAAR1 | |
| SCHEMBL29628985 | 0.67 | TAAR1 (0.65) | KDM4EMEN1MAPTKMT2ATAAR1 | |
| SCHEMBL16605628 | 0.67 | TAAR1 (0.65) | KDM4EMEN1MAPTKMT2ATAAR1 | |
| SCHEMBL16605626 | 0.67 | TAAR1 (0.65) | KDM4EMEN1MAPTKMT2ATAAR1 | |
| SCHEMBL177819 | 0.67 | — | — | |
| SCHEMBL30172705 | 0.67 | CYP2A6 (0.56) | KDM4EMEN1MAPTKMT2ATAAR1 | |
| SCHEMBL1205892 | 0.67 | TAAR1 (0.44) | KDM4EMEN1MAPTKMT2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115702174-B | Production of polypropylene with low volatiles | 博里利斯股份公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20230331881-A1 | PRODUCTION OF POLYPROPYLENE WITH LOW VOLATILES | BOREALIS AG (AT) | 2023-10-19 | — | — | US | disclosed |
| CN-114616280-B | Heterophasic propylene ethylene copolymer compositions with desirable balance of mechanical properties | 北欧化工公司 | 2023-10-13 | — | — | CN | disclosed |
| US-20230142911-A1 | OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION CATALYST PRODUCTION METHOD, AND OLEFIN POLYMER PRODUCTION METHOD USING THE OLEFIN POLYMERIZATION CATALYST | JAPAN POLYPROPYLENE CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-115702174-A | Production of polypropylene with low volatiles | 博里利斯股份公司 | 2023-02-14 | — | — | CN | disclosed |
| EP-4105246-A1 | CATALYST FOR OLEFIN POLYMERIZATION, PRODUCTION METHOD FOR CATALYST FOR OLEFIN POLYMERIZATION, AND PRODUCTION METHOD FOR OLEFIN POLYMER USING SAID CATALYST FOR OLEFIN POLYMERIZATION | Japan Polypropylene Corporation (JP) | 2022-12-21 | — | — | EP | disclosed |
| US-20220396695-A1 | HETEROPHASIC PROPYLENE ETHYLENE COPOLYMER COMPOSITION WITH DESIRABLE BALANCE OF MECHANICAL PROPERTIES | BOREALIS AG (AT) | 2022-12-15 | — | — | US | disclosed |
| CN-114616280-A | Heterophasic propylene ethylene copolymer compositions having a desirable balance of mechanical properties | 北欧化工公司 | 2022-06-10 | — | — | CN | disclosed |
| WO-2021254938-A1 | PRODUCTION OF POLYPROPYLENE WITH LOW VOLATILES | BOREALIS AG (AT) | 2021-12-23 | — | — | WO | disclosed |
| EP-3925986-A1 | PRODUCTION OF POLYPROPYLENE WITH LOW VOLATILES | Borealis AG (AT) | 2021-12-22 | — | — | EP | disclosed |
| EP-2915816-A1 | METALLOCENE COMPLEX AND OLEFIN POLYMERIZATION METHOD | Japan Polypropylene Corporation (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-2562166-B1 | 5-FLUORO PYRIMIDINE DERIVATIVES AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2015-08-19 | — | — | EP | disclosed |
| CN-104781270-A | Metallocene complexes and olefin polymerization process | JAPAN POLYPROPYLENE CORP | 2015-07-15 | — | — | CN | disclosed |
| EP-2360163-B1 | METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN | JAPAN POLYPROPYLENE CORP (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-8461365-B2 | Metallocene complex and polymerization method of olefin | JAPAN POLYPROPYLENE CORPORATION (JP) | 2013-06-11 | — | — | US | disclosed |
| CN-102245620-A | Metallocene complex and method for polymerizing olefin | JAPAN POLYPROPYLENE CORP | 2011-11-16 | — | — | CN | disclosed |
| US-20110230622-A1 | METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN | JAPAN POLYPROPYLENE CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| EP-2360163-A1 | METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN | Japan Polypropylene Corporation (JP) | 2011-08-24 | — | — | EP | disclosed |
| EP-1265870-A1 | NEW CCR5 MODULATORS: BENZIMIDAZOLES OR BENZOTRIAZOLES | AstraZeneca AB (SE) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001066525-A1 | NEW CCR5 MODULATORS: BENZIMIDAZOLES OR BENZOTRIAZOLES | ASTRAZENECA AB (SE) | 2001-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230622-A1 | METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN | ALOX12, ALOX15, ALOX15B | KDM4E 3839/4885MEN1 1018/4885MAPT 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.